413 related articles for article (PubMed ID: 30779470)
1. Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Liang S; Li H; Shen X; Liu R
J Clin Lab Anal; 2019 Jun; 33(5):e22864. PubMed ID: 30779470
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
[TBL] [Abstract][Full Text] [Related]
3. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
5. A simple angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
Chen G; Westra J; Yang X; Zhang Y; Luo D; Hu X; Li G; Zhou Y; Tu S; Dong H
Int J Cardiol; 2024 Aug; 409():132199. PubMed ID: 38782068
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
7. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Wang Z; Liu N; Ren L; Lei L; Ye H; Peng J
Arq Bras Cardiol; 2018 Apr; 110(4):333-338. PubMed ID: 29538502
[TBL] [Abstract][Full Text] [Related]
8. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
9. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
[TBL] [Abstract][Full Text] [Related]
10. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality.
Del Turco S; Basta G; De Caterina AR; Sbrana S; Paradossi U; Taddei A; Trianni G; Ravani M; Palmieri C; Berti S; Mazzone A
Int J Cardiol; 2019 Sep; 290():34-39. PubMed ID: 31079969
[TBL] [Abstract][Full Text] [Related]
11. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
Baek JY; Kang TS; Rha SW; Choi BG; Park SH; Jeong MH
Coron Artery Dis; 2018 Aug; 29(5):416-422. PubMed ID: 29708887
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
Şen Ö; Şen SB; Topuz AN; Topuz M
Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
[No Abstract] [Full Text] [Related]
13. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor-15 as a negative predictor for microvascular obstruction in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Wu X; Bai J; Tan Y; Wei Z; Dai Q; Kang L; Wang L; Chen J; Yang Y; Wang K; Wu H
Int J Cardiovasc Imaging; 2024 Apr; 40(4):863-871. PubMed ID: 38430425
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kacprzak M; Zielinska M
Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
[TBL] [Abstract][Full Text] [Related]
17. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction.
Bai S; Fu X; Gu X; Wang Y; Li W; Fan Y; Wei L; Bi X
Coron Artery Dis; 2016 Jun; 27(4):302-10. PubMed ID: 26945186
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
